Cargando…
FRI331 Autoimmune Hypophysitis Secondary To Ipilimumab And Nivolumab Combination Therapy In A Patient With Advanced Renal Cell Carcinoma
Disclosure: E.Y. Ibrahim: None. I. Hulinsky: None. D. Regelmann: None. Introduction: Ipilimumab and nivolumab combination therapy is an effective immune checkpoint inhibitor regimen indicated for advanced stages of renal cell carcinoma. Autoimmune hypophysitis is a rare adverse event from this thera...
Autores principales: | Ibrahim, Eiman Y, Hulinsky, Ilja, Regelmann, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553917/ http://dx.doi.org/10.1210/jendso/bvad114.1266 |
Ejemplares similares
-
SUN-416 Ipilimumab Associated Hypophysitis and Thyroiditis
por: Kazi, Fatima, et al.
Publicado: (2019) -
FRI339 Hypophysitis Secondary To Small Vessel Anca Vasculitistreated With Rituximab
por: Carmen Rivadeneira, Ana Del, et al.
Publicado: (2023) -
FRI342 Hypophysitis Mimicking As Pituitary Adenoma
por: Chao, Alex, et al.
Publicado: (2023) -
FRI326 Hypophysitis: A Formidable Diagnostic Challenge
por: Pandey, Shanta, et al.
Publicado: (2023) -
FRI328 Granulomatous Hypophysitis With Magnificent Response To Glucocorticoids
por: Rodriguez Caballero, Maria Galiana, et al.
Publicado: (2023)